1. Binding of YY1/CREB to an Enhancer Region Triggers Claudin 6 Expression in H. pylori LPS-Stimulated AGS Cells
    Jorge H. Romero-Estrada et al, 2023, International Journal of Molecular Sciences CrossRef
  2. CLDN6 inhibits breast cancer metastasis through WIP-dependent actin cytoskeleton-mediated autophagy
    Yuan Dong et al, 2023, Journal of Experimental & Clinical Cancer Research CrossRef
  3. Claudin 6: Therapeutic prospects for tumours, and mechanisms of expression and regulation (Review)
    Huan Du et al, 2021, Molecular Medicine Reports CrossRef
  4. Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
    Martina S.J. McDermott et al, 2023, Clinical Cancer Research CrossRef
  5. Association of CLDN6 and CLDN10 With Immune Microenvironment in Ovarian Cancer: A Study of the Claudin Family
    Peipei Gao et al, 2021, Frontiers in Genetics CrossRef
  6. Endothelial tight junctions and their regulatory signaling pathways in vascular homeostasis and disease
    Xin Cong et al, 2020, Cellular Signalling CrossRef
  7. CLDN6 inhibits colorectal cancer proliferation dependent on restraining p53 ubiquitination via ZO-1/PTEN axis
    Yuan Dong et al, 2023, Cellular Signalling CrossRef
  8. The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis
    Adrian Georg Simon et al, 2023, Journal of Translational Medicine CrossRef
  9. The expression and the tumor suppressor role of CLDN6 in colon cancer
    Huinan Qu et al, 2022, Molecular and Cellular Biochemistry CrossRef
  10. A SUMOylation-dependent HIF-1α/CLDN6 negative feedback mitigates hypoxia-induced breast cancer metastasis
    Yiyang Jia et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef
  11. The role and mechanism of claudins in cancer
    De-Wen Wang et al, 2022, Frontiers in Oncology CrossRef